Per AI
What the S-3 is actually doing
The key concept is registration of resale, not a new issuance of stock by CytoDyn.
The shares belong to existing shareholders. CytoDyn is essentially saying to the SEC:
"These shareholders own these securities, and we are registering them so they can legally resell them publicly."
CytoDyn itself does not receive the proceeds when those shareholders sell their shares. That is explicitly how its previous resale registration worked.
Why would several shareholders want this?
This is the part that can look alarming but is actually fairly routine.
Many of these investors acquired CYDY through private placements. In exchange for putting money into a very speculative company, they frequently negotiate registration rights.
In other words, their agreement with CytoDyn can effectively say:
"If we buy these restricted shares, you will register them so we can eventually sell them publicly."
CytoDyn's 2026 resale prospectus specifically says the registration was being done pursuant to registration rights granted to the selling stockholders.
So I wouldn't interpret "a group of shareholders" as necessarily meaning they got together and decided:
"Let's all dump CYDY."
It is more likely that they are investors from one or more financing transactions whose contractual registration rights are being exercised.
What the S-3 is actually doing
The key concept is registration of resale, not a new issuance of stock by CytoDyn.
The shares belong to existing shareholders. CytoDyn is essentially saying to the SEC:
"These shareholders own these securities, and we are registering them so they can legally resell them publicly."
CytoDyn itself does not receive the proceeds when those shareholders sell their shares. That is explicitly how its previous resale registration worked.
Why would several shareholders want this?
This is the part that can look alarming but is actually fairly routine.
Many of these investors acquired CYDY through private placements. In exchange for putting money into a very speculative company, they frequently negotiate registration rights.
In other words, their agreement with CytoDyn can effectively say:
"If we buy these restricted shares, you will register them so we can eventually sell them publicly."
CytoDyn's 2026 resale prospectus specifically says the registration was being done pursuant to registration rights granted to the selling stockholders.
So I wouldn't interpret "a group of shareholders" as necessarily meaning they got together and decided:
"Let's all dump CYDY."
It is more likely that they are investors from one or more financing transactions whose contractual registration rights are being exercised.
2
